Intuit Earnings Report Could Test Morgan Stanleys Stock Forecast
MLS Cup Shift to Memorial Day Could Boost League Revenue and Viewership
Wholesale Inflation Accelerates Producer Price Index Surges 6 Annually in April Largest Gain Since 2022
SP 500 Inches Higher as Healthcare and Tech Lead Communication Services Slips
Enhanced Games Donald Trump JrBacked Steroid Olympics Set for Sunday Debut with Broader Product Ambitions
Possible FirstDay Valuations for SpaceX OpenAI and Anthropic Could Surpass Berkshire Hathaway According to Polymarket Traders
BKD Q1 2026 Earnings EPS Misses Estimates by 35 as Senior Housing Operator Faces Headwinds
PONY Q1 2026 Earnings Narrower Loss Per ADS Drives Positive Investor Sentiment
LOCO Q1 2026 Earnings EPS Surges Past Estimates by 276 Shares Dip Slightly
AGI Q1 2026 Earnings EPS Misses Estimates Stock Declines on Profitability Concerns
FRPH Q4 2024 Earnings EPS of 009 Reported Stock Declines Slightly
ACI Q1 2026 Earnings EPS Beats Estimates by 1034 as Grocer Shows Resilience
NeOnc Technologies Holds Ground Near Key Support Amid Biotech Uncertainty NTHI
VICI Properties VICI Holds Steady Near 2850 as REIT Sector Weighs Macro Headwinds
Offerpad Solutions Inc OPAD Bounces 4 as Stock Holds Near Key Support
Oxford Square Capital OXSQ Surges 78 Breaking Past Key Support Level
Senti Biosciences Edges Higher Near Key Resistance Level
Amgen Announces CFO Peter Griffiths Retirement Succession Planning Underway
NEU Q1 2026 Earnings Strong EPS Performance Amidst Operational Stability
Insight Digital Partners II DYOR Edges Higher Near Resistance on Minimal Price Action
HSIC Q1 2026 Earnings EPS Beat of 631 Surprises Analysts
FLOC Q1 2026 Earnings Massive EPS Beat But Stock Declines
SFL Q1 2026 Earnings Stunning EPS Surprise of 1880 Despite Negative Stock Reaction
TSAT Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Amid Revenue Disclosures Still Pending
BHP Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Commodity Conditions
JMSB Q1 2026 Earnings EPS Beats Estimates Stock Rises 123
Outlook Therapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Surges 29